01865 261400

BOOK A TOUR

Absolute Antibody growth & investment accelerates

June 7th 2017

How these providers of engineered antibodies have seen significant progress with 195% growth over the previous year.

Absolute Antibody Ltd is pleased to announce strongly accelerated growth in the last two quarters, with year-on-year sales growth at 195%.

The custom business, where Absolute Antibody provides service specific to customers’ requirements has seen an increase in large orders, including antibody humanisation and bispecific antibody projects.

The catalogue has grown into a broad range of over 2500 ‘off the shelf’ products. There is continued demand for defined and reliable antibody reagents in the pharmaceutical research and diagnostics sectors, as well as in academia.

To better support its customers, Absolute Antibody will expand its operation in both the UK and USA. Increased production and R&D will take place in the UK, to support increased demand for engineered antibodies and continue to develop new and innovative technologies. A full distribution business will be established in the USA to provide full time in-field support for all customers there.

"Continued investment in people and processes allows us to support our customers’ individual needs whilst keeping pace with this high demand."

Dr Nicholas Hutchings - CEO of Absolute Antibody

"Our investment in a proprietary antibody manufacturing platform based on transient transfection ensured we could cater for expected significant increases in volume.” said Dr Nicholas Hutchings, CEO of Absolute Antibody, “Continued investment in people and processes allows us to support our customers’ individual needs whilst keeping pace with this high demand.”

New UK facilities in both Oxford and Redcar will go live over June and July, with USA expansion to follow.

October 11th 2023

Five minutes with NavLive co-founders Dr David Wisth and Prof Maurice Fallon

University of Oxford spinout NavLive has recently joined the community of inspiring deep-tech start-ups at our Oxford Centre for Innovation. With its advanced 3D mapping technology, it aims to create new norms in the complex management of building sites, bringing economic benefits to the building and construction sector. We spoke to its co-founders, […]

September 27th 2023

Fusion technology company Oxford Sigma relocates HQ to Oxford Centre for Innovation

Oxford Sigma has returned to Oxford’s city centre to accelerate fusion materials technology commercialisation to help tackle climate change and resolve energy security, with new global headquarters at our Oxford Centre for Innovation.

September 14th 2023

Oxford Sigma Annual Summer Internship Programme A Success For Next Generation Fusion Skills Development

This year saw Oxford Sigma’s largest internship intake to date over the summer of 2023.